Purinergic P1 Receptor Antagonists
"Purinergic P1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
Descriptor ID |
D058915
|
MeSH Number(s) |
D27.505.519.625.725.400.100 D27.505.696.577.725.400.100
|
Concept/Terms |
Purinergic P1 Receptor Antagonists- Purinergic P1 Receptor Antagonists
- P1 Purinoceptor Antagonists
- Antagonists, P1 Purinoceptor
- Purinoceptor Antagonists, P1
- Adenosine Receptor Antagonists
- Antagonists, Adenosine Receptor
- Receptor Antagonists, Adenosine
|
Below are MeSH descriptors whose meaning is more general than "Purinergic P1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Purinergic P1 Receptor Antagonists".
This graph shows the total number of publications written about "Purinergic P1 Receptor Antagonists" by people in this website by year, and whether "Purinergic P1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 | 1996 | 0 | 1 | 1 | 2002 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Purinergic P1 Receptor Antagonists" by people in Profiles.
-
Xie AX, Madayag A, Minton SK, McCarthy KD, Malykhina AP. Sensory satellite glial Gq-GPCR activation alleviates inflammatory pain via peripheral adenosine 1 receptor activation. Sci Rep. 2020 08 25; 10(1):14181.
-
Zettler ME, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY. Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study. Am Heart J. 2017 Jan; 183:62-68.
-
Grenz A, Zhang H, Weingart J, von Wietersheim S, Eckle T, Schnermann J, K?hle C, Kloor D, Gleiter CH, Vallon V, Eltzschig HK, Osswald H. Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol. 2007 Nov; 293(5):F1501-11.
-
Song Z, Sladek CD. Does conversion of ATP to adenosine terminate ATP-stimulated vasopressin release from hypothalamo-neurohypophyseal explants? Brain Res. 2005 Jun 14; 1047(1):105-11.
-
Petersen AM, Gleeson TT, Scholnick DA. The effect of oxygen and adenosine on lizard thermoregulation. Physiol Biochem Zool. 2003 May-Jun; 76(3):339-47.
-
Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 Mar 19; 105(11):1348-53.
-
Cleveland JC, Meldrum DR, Rowland RT, Sheridan BC, Banerjee A, Harken AH. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery. 1996 Aug; 120(2):345-52; discussion 352-3.
-
Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol. 1995 Aug; 269(2 Pt 2):H473-9.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|